Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A drug for treating nasal diseases

A drug and turbinate technology, applied in the field of drugs for the treatment of nasal diseases, can solve the problems of drug dependence, patients with high recurrence rate, and cure the symptoms but not the root cause, and achieve the effects of less toxic and side effects, low recurrence rate and good curative effect.

Active Publication Date: 2018-11-06
安龙县东方五官灵制品厂
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are many drugs for treating nasal diseases on the market, most of which can only treat symptoms, usually treat the symptoms but not the root cause, have a high recurrence rate and may cause patients to become dependent on drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] A medicine for treating rhinitis, comprising the following steps:

[0043] (1) Screening raw materials, weighing 12g of Danshen, 13g of Wang Buliuxing, 10g of Chuanxiong, 17g of Goose Bubio, 12g of Angelica dahurica, 17g of Magnolia, 8g of Scutellaria, 13g of Xanthium, 1g of Asarum, 1g of Borneol, washed ,Remove impurities;

[0044] (2) Mix all raw materials evenly, dry and sterilize by microwave;

[0045] (3) Soak in water for injection that is 10 times the total amount of raw materials for 30 minutes, decoct for 20 minutes, filter, and cool;

[0046] (4) Sterilize, subpackage, and put into storage after quality inspection.

Embodiment 2

[0048] A medicine for treating rhinitis, comprising the following steps:

[0049] (1) Screening raw materials, weighing 17g of Salvia miltiorrhiza, 8g of Wang Buliuxing, 15g of Chuanxiong, 12g of Goose Bubio, 17g of Angelica dahurica, 12g of Magnolia, 13g of Scutellaria baicalensis, 8g of cocklebur, 5g of asarum, 3g of borneol, washed ,Remove impurities;

[0050] (2) Mix all raw materials evenly, dry and sterilize by microwave;

[0051] (3) Soak in water for injection 15 times the amount of the API for 60 minutes, decoct for 30 minutes, filter, and cool;

[0052] (4) Sterilize, subpackage, and put into storage after quality inspection.

Embodiment 3

[0054] (1) Screening raw materials, weighing 15g of Salvia miltiorrhiza, 10g of Wang Buliuxing, 12g of Chuanxiong, 15g of Angelica dahurica, 15g of Magnolia, 10g of Scutellaria baicalensis, 10g of cocklebur, 3g of asarum, 1g of borneol, washed ,Remove impurities;

[0055] (2) Mix all raw materials evenly, dry and sterilize by microwave;

[0056] (3) Soak in water for injection 12 times the amount of the API for 45 minutes, decoct for 25 minutes, filter, and cool;

[0057] (4) Sterilize, subpackage, and put into storage after quality inspection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating rhinopathy. The medicine comprises the following active pharmaceutical ingredients in parts by weight: 12-17 parts of Danshen root, 8-13 parts of cowherb seed, 10-15 parts of Szechuan lovage rhizome, 12-17 parts of small centipeda herb, 12-17 parts of dahurian angelica root, 12-17 parts of flower bud of lily magnolia, 8-13 parts of baikal skullcap root, 8-13 parts of Siberian cocklour fruit, 1-5 parts of manchurian wildginger herb and 1-3 parts of borneol. The medicine is obtained by weighing the active pharmaceutical ingredients according to the parts by weight, washing, drying and sterilizing, soaking and decocting the active pharmaceutical ingredients, filtering the decoction, cooling the filtrate and re-sterilizing the filtrate. The medicine provided by the invention has the characteristics of quickness in effect taking, good curative effects and small side effects. The medicine is clinically used by totally 647 patients and the average cure rate is 92.8%. The medicine is convenient and fast to use.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a medicine for treating nasal diseases. Background technique [0002] The nose is an important portal and starting point of the human respiratory tract. Rhinopathy is an extremely common and frequently-occurring disease. [0003] The pathogenic factors of common nasal diseases include: (1) climate: when the temperature changes greatly, whether it is sudden cold or sudden heat, the nasal mucosa is easily irritated and prone to acute or chronic rhinitis; (2) surrounding environment: when When the working or living environment is dry, dusty or polluted by harmful substances, it is easy to irritate and damage the nasal mucosa; (3) Bad living habits: such as frequent nose picking and nose hair pulling, resulting in nasal skin damage and hair follicle damage. (4) improper medication: if the nose is dripped with vasoconstrictors for a long time, especially dripping nasal ne...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/575A61P11/02
CPCA61K9/0043A61K31/045A61K36/232A61K36/236A61K36/264A61K36/28A61K36/36A61K36/537A61K36/539A61K36/575A61K2300/00
Inventor 朱本宁
Owner 安龙县东方五官灵制品厂
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products